Topas Therapeutics GmbH

Topas Therapeutics is a clinical-stage biotechnology company transforming the field of immune tolerance with a novel antigen-specific and targeted nanoparticle technology. Our antigen-coupled nanoparticle platform harnesses the tolerogenic power of the liver to treat autoimmune diseases. Our proprietary Topas Particles Conjugates target liver sinusoidal endothelial cells, a specific type of antigen-presenting cells highly effective at inducing T cell tolerance. With a technology adjustable to a broad spectrum of disease-relevant antigens, we have established a growing and advanced clinical pipeline to induce systemic tolerance. To learn more visit https://topas-therapeutics.com

Autoimmune diseases,nanoparticle platform,liver,celiac disease,pemphigus vulgaris,and multiple sclerosis

Topas therapeutics gmbh operates in the Biotechnology research industry.

Topas therapeutics gmbh's revenue is 1m - 10m

Topas therapeutics gmbh has 11 - 50 employees.